SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-247553
Filing Date
2019-09-18
Accepted
2019-09-18 09:30:02
Documents
4
Period of Report
2019-09-18

Document Format Files

Seq Description Document Type Size
1 6-K d790223d6k.htm 6-K 9125
2 EX-99.1 d790223dex991.htm EX-99.1 62631
3 GRAPHIC g790223dsp5a.jpg GRAPHIC 5233
4 GRAPHIC g790223g0918165219646.jpg GRAPHIC 2906
  Complete submission text file 0001193125-19-247553.txt   84417
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 191098465
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences